Literature DB >> 26038210

Surgical management of adrenocortical carcinoma.

Gustavo G Fernandez Ranvier1, William B Inabnet2.   

Abstract

Adrenocortical carcinoma (ACC) is rare but one of the most malignant endocrine tumors. This article reviews and summarizes the current knowledge about the treatment of ACC. The epidemiology and molecular events involved in the pathogenesis of ACC are briefly outlined. The different diagnostic tools to distinguish benign from malignant adrenocortical tumors, including biochemical analysis and imaging, are discussed. The surgical treatment of ACC has evolved in the last 2 decades. The different surgical alternatives for the treatment of ACC in the context of primary, recurrent, or metastatic disease are reviewed, and the remaining challenges and controversies are discussed.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adrenocortical carcinoma; Adrenocortical tumor; Chemotherapy for adrenocortical carcinoma; Metastatic adrenocortical carcinoma; Mitotane treatment; Open adrenalectomy

Mesh:

Substances:

Year:  2015        PMID: 26038210     DOI: 10.1016/j.ecl.2015.02.008

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  5 in total

1.  Minimally Invasive Resection of Adrenocortical Carcinoma: a Multi-Institutional Study of 201 Patients.

Authors:  Christina W Lee; Ahmed I Salem; David F Schneider; Glen E Leverson; Thuy B Tran; George A Poultsides; Lauren M Postlewait; Shishir K Maithel; Tracy S Wang; Ioannis Hatzaras; Rivfka Shenoy; John E Phay; Lawrence Shirley; Ryan C Fields; Linda X Jin; Timothy M Pawlik; Jason D Prescott; Jason K Sicklick; Shady Gad; Adam C Yopp; John C Mansour; Quan-Yang Duh; Natalie Seiser; Carmen C Solorzano; Colleen M Kiernan; Konstantinos I Votanopoulos; Edward A Levine; Sharon M Weber
Journal:  J Gastrointest Surg       Date:  2016-10-21       Impact factor: 3.452

2.  Construction of a risk signature for adrenocortical carcinoma using immune-related genes.

Authors:  Yang Fu; Shanshan Sun; Jianbin Bi; Chuize Kong
Journal:  Transl Androl Urol       Date:  2020-10

3.  Outcomes after resection of cortisol-secreting adrenocortical carcinoma.

Authors:  Georgios Antonios Margonis; Yuhree Kim; Thuy B Tran; Lauren M Postlewait; Shishir K Maithel; Tracy S Wang; Jason A Glenn; Ioannis Hatzaras; Rivfka Shenoy; John E Phay; Kara Keplinger; Ryan C Fields; Linda X Jin; Sharon M Weber; Ahmed Salem; Jason K Sicklick; Shady Gad; Adam C Yopp; John C Mansour; Quan-Yang Duh; Natalie Seiser; Carmen C Solorzano; Colleen M Kiernan; Konstantinos I Votanopoulos; Edward A Levine; George A Poultsides; Timothy M Pawlik
Journal:  Am J Surg       Date:  2015-12-31       Impact factor: 2.565

4.  Surgical resection of adrenocortical carcinoma with invasion into the inferior vena cava: a case report and literature review.

Authors:  Minchun Jiang; Huanyu Ding; Cheng Li; Kexu Xiang; Juying Tang; Ying Guo; Shaoling Zhang
Journal:  Clin Case Rep       Date:  2017-10-11

5.  Expression patterns and prognostic value of m6A RNA methylation regulators in adrenocortical carcinoma.

Authors:  Yang Fu; Shanshan Sun; Jianbin Bi; Chuize Kong; Lei Yin
Journal:  Medicine (Baltimore)       Date:  2021-03-12       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.